Comprehensive Care for Liver Disease
What we do
We treat a wide range of liver diseases, including fatty liver (NAFLD/NASH), alcoholic liver disease, cirrhosis, hepatic encephalopathy, hepatitis B and C, portal hypertension, and liver cancer.
Our specialists also manage patients requiring liver transplantation, providing coordinated care before and after surgery.
Through the Houston Research Institute, we conduct cutting-edge research to advance treatment options and improve outcomes.
We also offer a FibroScan®, a non-invasive test that measures liver fat and fibrosis (scarring) to better understand your liver health.
(Must meet qualifying factors.)
Bridging care and discovery to transform healthcare—where patient-centered treatment paves the way for a healthier future.
— Houston Liver Institute
Our Mission
Our mission is to provide state-of-the-art, compassionate hepatology care to patients affected by fatty liver, cirrhosis, and other complex liver diseases across the Greater Houston area and beyond.
To achieve these goals, we are committed to providing:
-
Outstanding, personalized patient care
-
Access to clinical liver research focused on the causes, prevention, and treatment of liver disease
-
Excellence in teaching and training clinicians and scientists in both patient care and liver research
-
Our facility was designed to accommodate cutting-edge diagnostic tools, chronic disease management, and clinical trials of novel therapies for patients with various liver conditions.
Come in today to learn more about your liver health and explore personalized options for care and treatment.
1 in 3 Americans
have Non-Alcoholic Fatty Liver Disease (NAFLD) or Non-Alcoholic Steatohepatitis (NASH)
…and many of them may not know it.
Meet Mazen Noureddin, MD, MHSc
Medical Director
Houston Liver Institute
Mazen Noureddin, MD, MHSc
Medical Director
“Life isn't about finding yourself. Life is about creating yourself.”
Dr. Mazen Noureddin is an internationally recognized hepatologist and a leading authority in fatty liver disease (NAFLD/NASH). Before founding the Houston Liver Institute and Houston Research Institute, he directed the Fatty Liver Program at Cedars-Sinai Medical Center in Los Angeles—ranked among the top gastrointestinal programs in the nation.
Dr. Noureddin completed his internal medicine residency at the University of Southern California (USC), followed by a fellowship in hepatology at the National Institutes of Health (NIH) and a gastroenterology fellowship at the University of California, San Diego (UCSD). He also holds a Master of Health Sciences in Clinical Research from the NIH/Duke University program.
Renowned for his pioneering research, Dr. Noureddin has led more than 40 clinical trials focused on innovative treatments for fatty liver disease and NASH-related cirrhosis. His work has shaped global understanding of non-invasive testing, fibrosis, and biomarkers of liver disease.
He regularly lectures at international liver congresses, including the American Association for the Study of Liver Diseases (AASLD) and the European Association for the Study of the Liver (EASL), and serves on multiple national and industry advisory boards. Dr. Noureddin is also Vice Chair of the AASLD NASH Special Interest Group and serves on the editorial boards of Clinical Gastroenterology and Hepatology (CGH), Hepatology, and Gastroenterology.
His research has been published in The Lancet, Science Translational Medicine, Journal of Hepatology, and Journal of Clinical Investigation, among others.
Today, Dr. Noureddin continues to advance his mission of bridging care and discovery—bringing patients in Houston and beyond access to world-class hepatology care and clinical innovation.
1155 Dairy Ashford Road, Suite 200
Houston, TX 77079
Email: info@houstonliverinstitute.com
Phone: 281-936-9369 | Fax: 281-809-3287
© 2025 Houston Liver Institute | Bridging Care and Discovery -All Rights Reserved